SynthesisThe Cochrane database of systematic reviews2018

Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.

Smita Pattanaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.